Trial Profile
A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin With Factorial Evaluation of Irbesartan for the Prevention of Vascular Events in Patients With Atrial Fibrillation
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2019
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Myocardial infarction; Stroke; Thromboembolism; Vascular disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms ACTIVE; ACTIVE-W
- Sponsors Sanofi
- 04 Aug 2019 Results (n=962) of post-hoc analysis assessing thrombooembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment of this and ACTIVE-A trial published in the European Heart Journal
- 14 Nov 2009 Results presented at the 82nd Annual Scientific Sessions of the American Heart Association (AHA 2009).
- 20 Oct 2009 Actual patient number (6706) added as reported by ClinicalTrials.gov.